It’s been a whirlwind fall season at Biorasis, a startup biomedical company at UConn.

First, the company — which is developing a device to monitor blood sugar levels in diabetics — won a $200,000 grant to test its product on the International Space Station. Then Biorasis won a prize of $100,000 in a technology competition in Massachusetts.

The company’s product, “Glucowizzard,” is an ultra-tiny wireless biosensor designed by Biorasis on the UConn campus. Smaller than a grain of rice, it is implanted under the skin and continuously monitors glucose levels, relaying data in real time to wristwatch-like receiver as well as a smartphone. The biosensor lasts from three months to a year.